ScienceDex / Researcher record
Stephen Lev Hoffman
- Sanaria, Inc. (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
Start from a Word CV, PubMed IDs or ORCID.
- Program Leader
- Top 10% Funded
- Early Career
- Diverse Portfolio
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $4,188,350 | 5 | #1,497 |
| 2025 | $2,940,565 | 3 | #3,531 |
| 2026 | $2,000,000 | 2 | #10,514 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected5 records
- FY20253 records
- FY20262 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1978462Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2024 award records by amount
NIH award records listing Stephen Lev Hoffman as a PI. Multi-PI records show the full award amount for context.
- 2U44AI124867-06U44Co-investigatorManufacture of aseptic, purified, cryopreserved Plasmodium vivax sporozoites$1Maward amount
- 5SB1AI174403-02SB1Contact PIProgressing PfSPZ vaccines for malaria to licensure and commercialization$999.3Kaward amount
- 5R44AI125009-06R44Contact PIA glycolipid adjuvant to promote dose sparing, accelerate immunization schedules and extend durability of high-level protection with an attenuated, live sporozoite malaria vaccine$968.4Kaward amount
- 5U01AI155354-04U01Contact PIDevelopment of Non-Human Primate Models to Assess Immunological Mechanisms and Antigenic Targets of Protective Sporozoite (SPZ) Vaccines and Establish Superior Efficacy of Next Generation SPZ vaccines$942.9Kaward amount
- 5R43AI179439-02R43Contact PIModularizing manufacture of PfSPZ vaccines: ookinete production for PfSPZ manufacture in mosquitoes and in vitro$277.7Kaward amount
Award organization
Organizations that administered FY2024 awards listing Stephen Lev Hoffman as a PI.
FY2024 award administered by Sanaria, Inc. (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardSanaria, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1497
- 2024Entered Top 25% NationallyRanked #1497
- 2024Entered Top 10% NationallyRanked #1497
- 2025$5M Cumulative Funding
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Stephen Lev Hoffman.